Headquartered in Stamford, CT Fiscal year ends December NYSE: PM pmi.com
Philip Morris International is a global consumer goods company primarily focused on cigarettes and smoke-free products, including heat-not-burn (IQOS), nicotine pouches (ZYN), and e-vapor (VEEV) products. The company operates through three reportable segments: International Smoke-Free, International Combustibles, and U.S. (including its wellness business unit, Aspeya). PMI's smoke-free products are available in 110 markets and accounted for more than 40% of Q3 2026 net revenues, used by over 43 million legal-age consumers worldwide. The company holds approximately three-quarters of global HTU volume share through IQOS and has invested over $16 billion since 2008 in developing and commercializing smoke-free alternatives. In the U.S., ZYN nicotine pouches have secured 31 PMTA-authorized variants and 20 Modified Risk Tobacco Product authorizations from the FDA. Key cigarette brands include Marlboro, which holds an 11.4% global category share. PMI has a long-term ambition to expand into wellness areas through its Aspeya business unit. Updated
A 5.6% move to $197.20 is outsized for a $307 billion defensive name that rarely trades like this, and it lands the same day the Q3 earnings report hit EDGAR. Keep an eye on whether the gain holds into the close.
A 3.88% intraday jump is a big day for a $302 billion defensive name, and it follows this morning's Q3 earnings filing. Management's outlook is what sets the next leg.
Income investors just got a raise: the dividend rose 8.8% to $1.60 a quarter, funded by smoke-free products that now clear 40% of net revenue. Both lines topped consensus, and management nudged full-year EPS guidance only for currency.
A 4.56% slide to $199.84 wipes roughly $14 billion off a $311.5 billion consumer-staples name that rarely moves like this. The $200 line is the level to keep an eye on from here.
A 3.5% slide to $202.08 strips roughly $11 billion from a $315 billion defensive name that rarely moves this hard in a single session. Keep an eye on whether it holds that level into the close.
Philip Morris cleared $200 for the first time, topping its late-July peak and putting a $312.6 billion tobacco name back in price discovery after ten weeks of chop below the line.
A 3% intraday gain to $200.88 adds roughly $9 billion of market value to a $313 billion defensive name that rarely moves this much in a single session. The $200 handle is the level to watch from here.
Altria spent a decade writing down bad bets, watching cigarette volumes shrink, and losing ground on smoke-free products. Yet investors who stuck around still came out ahead, and the reason has almost…
Philip Morris just handed shareholders its biggest dividend jump in years, but a $43 billion debt load and a yield compressed by a scorching rally raise real questions about how long this…
When paychecks stop, a portfolio has to pull its own weight, and the 10-year Treasury now sets a brutally high bar for any dividend stock trying to justify its place in a…
Four companies kept raising their dividends even as the pandemic hammered their sectors in 2020, and they are still raising today. The question is whether their yields and valuations make them worth…
A retiree living off a portfolio needs income that keeps coming. The First Trust Morningstar Dividend Leaders Index Fund (NYSEARCA:FDL) has paid distributions four times a year since 2006. FDL tracks Morningstar’s…
A $100,000 dividend portfolio spread across five names generates thousands in annual income, but the account type you choose determines how much of that income you actually keep rather than hand over…
Both tobacco giants just raised their dividends and both stocks are up over 28% this year, but the one paying nearly twice the yield may actually be the riskier bet for retirees…
A fat dividend yield means nothing if the cash runs dry before the check clears. These five companies show wildly different margins of safety, and one of them barely cleared the bar…
From a pharma giant rebuilding after a blockbuster patent loss to a pipeline partnership targeting double-digit distribution raises through 2027, these five stocks span wildly different industries yet share one thing: cash…
Altria's 6.6% yield and 60 consecutive raises look bulletproof until you dig into what sits beneath them: a shrinking core business, a failed smoke-free pivot, and a balance sheet with liabilities that…
Four dividend stocks from Philip Morris to JPMorgan Chase have ex-dates landing within days, and missing the cutoff means the payout goes to the seller. The clock is already running.
Both BTI and PM fund generous dividends from a shrinking cigarette business, but one company's smoke-free pivot has already changed what its payout is built on, and that gap matters far more…
Philip Morris and Altria both just raised their dividends, but the gap between them runs far deeper than yield percentages and payout sizes. Which tobacco giant actually deserves a spot in a…
Where you park a high-yield dividend stock can quietly cost you thousands in taxes every single year, and REITs and MLPs carry the steepest penalty of all for investors sitting in the…
Tobacco companies spend almost nothing on new equipment yet generate billions in cash, and a handful of US-listed names funnel that surplus straight into shareholder pockets through yields that most sectors cannot…
Philip Morris International is a global consumer goods company primarily focused on cigarettes and smoke-free products, including heat-not-burn (IQOS), nicotine pouches (ZYN), and e-vapor (VEEV) products.
24/7 Wall St.'s 12-month price target for PM is $221.90, rated Buy. The Wall Street consensus target is $208.71. PM price prediction →
